No Data
TrueData---Welcia Pharmacy has introduced the AI service "SalesSensor".
True Data <4416> announced on the 14th that Welcia Holdings <3141>'s group company, Welcia Pharmacy, will implement the company's AI service "SalesSensor" to improve sales forecast accuracy for new store openings. In the Retail Trade industry, when planning new store openings, the market area data around potential properties and sales performance data of existing stores are analyzed to determine the feasibility of recovering investments. Welcia examines hundreds of new store candidates annually.
TrueData---Significant profit increase in Q3, promoting the strengthening of profit structure.
True Data <4416> announced on the 14th its financial results for the third quarter of the fiscal year ending March 2025 (April to December 2024). Revenue decreased by 5.1% year-on-year to 1.132 billion yen, operating profit increased by 410.2% year-on-year to 0.041 billion yen, ordinary profit increased by 471.3% year-on-year to 0.04 billion yen, and quarterly net profit increased by 356.1% year-on-year to 0.005 billion yen. In the cumulative period of the third quarter, the company focused on expanding sales of its flagship service "Eagle Eye" targeted at consumer goods manufacturers, as well as small
Info MT ETC [Stocks with intriguing potential seen from Volume changes]
Stock Name Closing Price Change Volume* <2526> NZAM 400 25285 35 14930* <2517> MXSJ REIT Core 1011.53.5 102090* <6149> Odawara Engine 1849219130500* <7092> FFJ 1456216368900* <4167> Cocopelli 39641347000* <3997> Trade Works 1573247194000* <249
Individual stock information.
The technology succession organization <319A.T> (Growth) (Metal Products) reached its limit-up. It announced its financial results for the previous December period, showing consolidated operating profit of 1.517 billion yen (a 72.6% increase compared to the previous period). Meanwhile, the company is promoting business expansion through mergers and acquisitions (M&A) and is focusing on adjusted EBITDA (operating profit + depreciation + goodwill amortization + acquisition-related costs), which was 2.155 billion yen in the previous period (an increase of 27.1%) and is expected to be 2.4 billion yen this period (an increase of 11.4% compared to the previous period). IIF <65
True Data: Presentation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
True Data: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
International Equities Are Beating U.S. Stocks in 'Rare' Outperformance. Should You Lighten up on Non-U.S. Equities?